Studies on the Biotransformation of Veratric Acid, a Human Metabolite of Mebeverine, by Using the Incubated Hen’s Egg

Abstract

Metabolism studies with selected test substances have shown that a model on the basis of the incubated hen’s egg is suitable as a supplement to animal experimentation. Because of its 3,4-dimethoxyphenyl structure veratric acid (3,4-dimethoxybenzoic acid), a known human metabolite of mebeverine, was chosen as model substance for the present investigations and the parent compound as well as 4-hydroxy-3-methoxybenzoic acid were identified as main metabolites. The absence of 3-hydroxy-4-methoxybenzoic acid lets conclude that the O-demethylation takes place exclusively at the p-methoxyl function. In addition, 3,3’,4,4’-tetramethoxy-l-ornithuric acid (2,5-bis-(3,4-dimethoxybenzoylamino)pentanoic acid) and its O-desmethyl derivative could be characterized as further metabolites. So far an amino acid conjugate has not been described after veratric acid administration in a vertebrate. There were no indications for the appearance of 3,4-dihydroxybenzoic acid in the veratric acid metabolism. This was confirmed by corresponding studies having the isomeric guaiacol acids as precursor. Furthermore, it could be proved that in ovo the O-methylation of 3,4-dihydroxybenzoic acid occurs regioselective at the m-hydroxyl group. The results which broaden the knowledge on the metabolic fate of veratric acid are discussed in comparison with those in mammals. The metabolites were identified by GC-MS, ESI-HRMS and LC/ESI-MS/MS. The structure of the synthesized reference substance was confirmed by MS, ¹H and ¹³C NMR spectral data.

Key words

complementary method to animal testing - 3,4-dimethoxyphenyl moiety - guaiacol acids - O-demethylation - O-methylation - amino acid conjugation

• References

• 1 Fasinu P, Bouic PJ, Rosenkranz B. Liver-based in vitro technologies for drug biotransformation studies: a review. Curr Drug Metab 2012; 13: 215-224
• 2 Tingle MD, Helsby NA. Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?. Environ Toxicol Pharmacol 2006; 21: 184-190
• 3 Hung MW, Zhang ZJ, Li S et al. From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound. Evid Based Complement Alternat Med. 2012 DOI: 10.1155/2012/605303
• 4 Wheeler GN, Brändli AW. Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus. Dev Dyn 2009; 238: 1287-1308
• 5 Kiep L, Bekemeier H. Biotransformation and toxicity of xenobiotics in the chick embryo. Part I. Embryonated hen’s egg as in vivo model and sodium salicylate as substrate. Pharmazie 1986; 41: 868-872
• 6 Kiep L. Metabolism of xenobiotics in the incubated hen’s egg: Investigations with ethyl 4-hydroxybenzoate. ALTEX 2005; 22: 135-141
• 7 Neugebauer M. Biotransformation of (+)-methamphetamine in the embryonated hen’s egg. Pharmazie 1995; 50: 201-206
• 8 Kristinsson J, Snorradottir I, Johannsson M. The metabolism of mebeverine in man: Identification of urinary metabolites by gas chromatography/mass spectrometry. Pharmacol Toxicol 1994; 74: 174-180
• 9 Kraemer T, Bickeboeller-Friedrich J, Maurer HH. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: Gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine. Drug Metab Dispos 2000; 28: 339-347
• 10 Müller-Enoch D, Thomas H, Holzmann P et al. Metabolism of 3,4-dimethoxybenzaldehyde and 3,4-dimethoxybenzoic acid in perfused rat liver. Z Naturforsch 1974; 29C: 602-607
• 11 Panoutsopoulos GI, Beedham C. Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared guinea pig liver slices. Cell Physiol Biochem 2005; 15: 89-98
• 12 Kasuya F, Igarashi K, Fukui M. Glycine conjugation of the substituted benzoic acids in vitro: Structure-metabolism relationship study. J Pharmacobiodyn 1990; 13: 432-440
• 13 Midha KK, Bailey K, Cooper JK. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey. Xenobiotica 1979; 9: 485-490
• 14 Solheim E, Scheline RR. Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers. Xenobiotica 1976; 6: 137-150
• 15 Strand LP, Scheline RR. The metabolism of vanillin and isovanillin in the rat. Xenobiotica 1975; 5: 49-63
• 16 Fleschhut J. Untersuchungen zum Metabolismus, zur Bioverfügbarkeit und zur antioxidativen Wirkung von Anthocyanen. PhD thesis. 2004. University of Karlsruhe; Germany:
• 17 Price J. The metabolites of isovanillic acid in man, with special reference to the formation of 3,4-dimethoxybenzoic acid. Clin Chim Acta 1969; 25: 31-37
• 18 Wilson ID, Nicholson JK. Topics in xenobiochemistry: Do metabolic pathways exist for xenobiotics? The micro-metabolism hypothesis. Xenobiotica 2003; 33: 887-901
• 19 Xu M, Zhang Z, Fu G et al. Liquid chromatography-tandem mass spectrometry analysis of protocatechuic aldehyde and its phase I and II metabolites in rat. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 856: 100-107
• 20 Steventon GB, Hutt AJ. The amino acid conjugations. In: Ioannides C. (ed.). Enzyme systems that metabolise drugs and other xenobiotics. Chichester: John Wiley & Sons; 2002: 501-520
• 21 Russel WMS, Burch RL. The principles of humane experimental technique. London: Methuen; 1959
• 22 NRC . Toxicity testing in the 21^st century: a vision and a strategy. Washington DC: National Academy Press; 2007
• 23 Kiep L, Burkhardt J, Seifert K. Drug metabolism studies with the incubated hen’s egg: Identification of 2,3,5-trihydroxybenzoic acid as a metabolite of gentisic acid. Arzneimittelforschung 2008; 58: 469-474
• 24 Neugebauer M. Biotransformation von Arzneistoffen im Hühnerei: Eine Alternative zum Tierversuch. Habil thesis. 1997. University of Bonn; Germany:
• 25 Dong QG, Gu JK, Zhong DF et al. Metabolism of SFZ-47 in chicken embryo by liquid chromatography-electrospray ion trap mass spectrometry. Acta Pharmacol Sin 2003; 24: 576-580
• 26 Clement B, Mladek C. Investigation of biotransformation processes in the embryonated hen’s egg. Part I. Biotransformation of 7-ethoxycoumarin. Pharmazie 1995; 50: 207-210
• 27 Wehking-Bröker U. Untersuchungen zum kinetischen Verhalten von Phenacetin und Diazepam im bebrüteten Hühnerei. PhD thesis. 2000. University of Osnabrueck; Germany:
• 28 Kiep L, Maderner S, Seifert K. Metabolism of metamizol in early stages of the incubated hen’s egg. Pharmazie 2002; 57: 829-833
• 29 Carro T. Development and evaluation of a viable chicken egg assay to determine the metabolic fate of xenobiotic and other teratogenic compounds. PhD thesis. 2007. University of Delaware; USA:
• 30 Devarakonda RK, Narasaiah N, Vidyasagar J. Metabolism of metronidazole in early stages of chick embryo. A novel model for human metabolism. World Conference on Magic Bullets. Celebrating Paul Ehrlich’s 150^th Birthday. 2004. Sep 9–11 Nürnberg; Germany:
• 31 Wessel JC, Matyja M, Neugebauer M et al. Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen’s egg and human. Eur J Pharm Sci 2006; 28: 15-25
• 32 Clement B, Mladek C. Investigation of biotransformation processes in the embryonated hen’s egg. Part II. Metabolic conversion of p-nitrophenol. Pharmazie 1996; 51: 882-885